This compound is a pharmaceutical intermediate used in the manufacturing process of iguratimod. It features a tetracyclic ring system with hydroxyl and ester functional groups.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Ethyl 2-(7-((4-cyclopentyl-3-(trifluoromethyl)benzyl)oxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetate
pharmaceutical intermediate
N-(5-(4-formylphenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide
pharmaceutical intermediate
N-(5-(4-(bromomethyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide
pharmaceutical intermediate
(5-Bromo-3-(trifluoromethyl)pyridin-2-yl)methanol
pharmaceutical intermediate
Etrasimod Impurity 42
pharmaceutical intermediate
1,2,3,4-Tetrahydro-7-methoxycyclopent[b]indole-3-acetic acid
research reagent
ethyl 2-(7-hydroxy-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetate
QPXXHQCMPZUYDB-UHFFFAOYSA-N
CCOC(=O)CC1CCC2=C1NC3=C2C=C(C=C3)O
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.